Implantica Plans First Quarter 2025 Presentation on May 9

Join Implantica for Their Upcoming First Quarter Presentation
Implantica AG (publ) invites all interested investors to join the presentation of the first quarter results for 2025. This highly anticipated event will take place at 15:00 CEST on May 9. To ensure that attendees have ample time to prepare, the interim report will be published on the same day at 8:00 a.m. CEST.
How to Participate in the Live Presentation
For those wishing to participate via webcast, you will find all the necessary information and a link to join on the Implantica website. The live audio presentation is designed to be informative and engaging, providing insights into the company’s latest performance and innovations.
Dial-in Options for Investors
If you prefer to join the conference call, registration is required in advance. Once registered, participants will receive a unique phone number and conference ID, ensuring easy access to the live discussion.
Meet the Leadership Team
The presentation will feature leading figures from the company, including:
- CEO Peter Forsell
- CFO Andreas Öhrnberg
- Chief Corporate Affairs Officer Nicole Pehrsson
Contact for Additional Information
For any inquiries regarding the upcoming presentation or company details, please reach out to Nicole Pehrsson, who oversees Investor Relations. She is available by phone for direct communication and further assistance.
About Implantica
Implantica is a pioneering medtech group focused on introducing advanced medical technologies to enhance health outcomes. The flagship product, RefluxStop™, is a groundbreaking implant aimed at preventing gastroesophageal reflux. This innovative solution is backed by strong clinical trial results and promises to transform the landscape of anti-reflux treatment.
Beyond this, Implantica places significant emphasis on eHealth solutions. The company’s portfolio includes a variety of patented technologies that monitor health metrics, control treatments internally, and offer communication capabilities for caregivers from a distance. This comprehensive approach underscores Implantica's commitment to improving patient care and outcomes.
Stay Updated with Implantica's Progress
Implantica is listed on the Nasdaq First North Premier Growth Market, and shareholders can expect regular updates on the company's innovations and strategies for growth. To explore their advancements and learn more about their vision, visiting the corporate website will provide further insights and information.
Frequently Asked Questions
When will Implantica's first quarter presentation take place?
The presentation is scheduled for May 9, 2025, at 15:00 CEST.
How can I participate in the presentation?
You can participate via webcast or telephone conference by registering in advance.
Who are the key speakers at the presentation?
Key speakers include CEO Peter Forsell, CFO Andreas Öhrnberg, and Chief Corporate Affairs Officer Nicole Pehrsson.
What is Implantica's primary product?
Implantica's primary product is RefluxStop™, designed to prevent gastroesophageal reflux.
Where is Implantica listed?
Implantica is listed on the Nasdaq First North Premier Growth Market.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.